Pending — not yet graded
“Motilal Oswal lowered Dr Reddy's Laboratories' FY27 EPS estimate by 19% to ₹37.2 from ₹45.9, anticipating a 37% decline in FY27 earnings before a significant 61.3% recovery in FY28.”
Motilal Oswal Analysis’s track record: 6 graded calls · 95% CI 19–81%
Dr Reddy's LaboratoriesBearishCalled 21 Aug 2026
This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.
Pre-fills a same-day INTRADAY short — delivery short-selling isn't allowed, so this is the only way to paper-trade a bearish call.